Gary Wittert

Active 1992–2025

176
Papers
19,498
Citations
85
h-index
169
i10-index

Citations

Citations per year for Gary Wittert1976: 1 citations1993: 1 citations1994: 1 citations1995: 2 citations1996: 1 citations1997: 8 citations1998: 21 citations1999: 25 citations2000: 21 citations2001: 37 citations2002: 24 citations2003: 29 citations2004: 81 citations2005: 73 citations2006: 81 citations2007: 73 citations2008: 78 citations2009: 87 citations2010: 90 citations2011: 70 citations2012: 119 citations2013: 137 citations2014: 153 citations2015: 168 citations2016: 185 citations2017: 195 citations2018: 184 citations2019: 579 citations2020: 604 citations2021: 686 citations2022: 594 citations2023: 477 citations2024: 828 citations2025: 426 citations2026: 16 citations1977–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,882 citing papers, 20.8% of this breakdownAustralia: 876 citing papers, 9.7% of this breakdownUnited Kingdom: 750 citing papers, 8.3% of this breakdownChina: 515 citing papers, 5.7% of this breakdownItaly: 458 citing papers, 5% of this breakdownGermany: 394 citing papers, 4.3% of this breakdownCanada: 371 citing papers, 4.1% of this breakdownNetherlands: 296 citing papers, 3.3% of this breakdownSpain: 255 citing papers, 2.8% of this breakdownFrance: 231 citing papers, 2.5% of this breakdownDenmark: 223 citing papers, 2.5% of this breakdownBelgium: 154 citing papers, 1.7% of this breakdown
0%20.8%Other 29.3%

Fields

  • Medicine78.3%
  • Neuroscience8.1%
  • Biochemistry, Genetics and Molecular Biology4.4%
  • Psychology3.8%
  • Nursing1.6%
  • Health Professions1.3%
  • Other2.5%

Topics

  • Diet and metabolism studies5.8%
  • Hormonal and reproductive studies3.8%
  • Dietary Effects on Health3.2%
  • Diabetes Treatment and Management3.1%
  • Pharmacology and Obesity Treatment2.6%
  • Regulation of Appetite and Obesity2.2%
  • Other79.3%

Coauthors

All papers

Open in search
  1. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudhesh Kumar, Carel Wynard le Roux, Michael E. J. Lean, Barbara McGowan, Michael E.J. Lean, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, AG Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos, G. Lieberman, Ilan Shimon and 104 more - The Lancet 2017 cited by 844

  2. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation

    Authors: , , , , , , , , , , - European Journal of Preventive Cardiology 2022 cited by 334

  3. Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , - JAMA 2013 cited by 760

  4. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Richard J. MacIsaac, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Peter G. Colman, David Colquhoun, Chris Ellis, Kim Joshua, Eugenia Pedagogos, Paul Regal, Duncan J. Topliss, James Vandeleur, Johan Verjans, Gary Wittert, Katie-Jane Wynne, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer, Bernhard Paulweber, Rudolf Prager, Wolfgang Preiß, Friedrich C. Prischl, G. Schernthaner, Harald Sourij, Martin Wiesholzer, Heinz Drexel, Rainer Oberbauer, Hans‐Robert Schönherr, Peter Doubel, W. Engelen, Pieter Gillard, Jean‐Michel Hougardy, Jean-Marie Krzesinski, Bart Maes, Marijn M. Speeckaert, Koen Stas, Luc Van Gaal, Hilde Vanbelleghem, Francis Duyck, André Scheen, Daniela Antunes, Roberto Botelho, Cláudia Brito, Luís Henrique Santos Canani, Maria Eugênia Fernandes Canziani, Maria Cerqueira, Rogério de Paula, Freddy G. Eliaschewitz, Carlos Eduardo Poli‐de‐Figueiredo, Adriana Costa e Forti, Miguel Nasser Hissa, Maurilo Leite, Emerson de Lima, Irene L. Noronha, Bruno Paolino and 1,242 more - Diabetes Care 2022 cited by 199

  5. Time‐Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial

    Authors: , , , , , , - Obesity 2019 cited by 462

  6. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 350

  7. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial

    Authors: , , , , , , , , , , , - Nature Medicine 2023 cited by 138

  8. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Ehud Grossman, Yoram Yagil, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan DeLeon, Janusz Gumprecht, Fernando Teixeira e Costa, Alexander Dreval, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda F. Fried, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer and 1,447 more - Annals of Internal Medicine 2023 cited by 88

  9. Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2011 cited by 490

  10. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation

    Authors: , , , , , , , , , , , , , , , - Heart Rhythm 2012 cited by 398

  11. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial

    Authors: , , , , , , , - American Journal of Clinical Nutrition 2015 cited by 343

  12. Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 668

  13. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial

    Authors: , , , , , , , , , , - BMJ 2014 cited by 485

  14. Co‐morbid OSA and insomnia increases depression prevalence and severity in men

    Authors: , , , , , , , , , - Respirology 2017 cited by 109

  15. A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial

    Authors: , , , , , , , - Diabetes Care 2014 cited by 262

  16. Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight

    Authors: , , , , , , , - Obesity 2018 cited by 148

  17. Factors Associated With Circulating Sex Hormones in Men

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary Wittert, Frederick C. W. Wu, Bu B. Yeap - Annals of Internal Medicine 2023 cited by 40

  18. Age-specific population centiles for androgen status in men

    Authors: , , , , , - European Journal of Endocrinology 2015 cited by 120

  19. Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2022 cited by 63

  20. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

    Authors: , , , , , , , , , , - The Medical Journal of Australia 2016 cited by 131

  21. Intermittent fasting increases energy expenditure and promotes adipose tissue browning in mice

    Authors: , , , , - Nutrition 2019 cited by 70

  22. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta‐analysis of randomized controlled clinical trials

    Authors: , , , - Clinical Endocrinology 2014 cited by 138

  23. Diet‐induced adaptation of vagal afferent function

    Authors: , , , , , , , , - The Journal of Physiology 2011 cited by 134

  24. Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

    Authors: , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2021 cited by 68